Tamika Jean-Baptiste

Vice President & Chief Diversity Officer Amgen Inc.

Tamika has over 25 years in the biopharmaceutical space and began her career journey with Johnson & Johnson. Tamika joined Amgen in 2001 as a specialty sales representative in Dallas TX. Over the past 19 years, she has gained diverse experiences including sales/account management leadership, marketing and value & access to medicine. She has been the recipient of multiple Amgen pinnacle awards including Chairman’s Circle, Team Excellence, Marketer of the Year and Coach of the Year. Tamika currently serves as the lead for Global Diversity, Inclusion & Belonging (DI&B) at Amgen and is responsible for shaping strategies to ensure our workforce reflects the globally diverse communities we serve while maintaining an environment where this diverse workforce can fully contribute to our mission to serve patients. Throughout her career, Tamika has been a champion for diversity, inclusion and belonging. Personally & professionally Tamika feels an inherent responsibility to support and mentor others to find their authentic voice and professional purpose. Tamika has served as the Global Co-Chair for Amgen Black Employee Network (ABEN) and was an integral part of the leadership team that launched the first field-based Employee Resource Group (ERG) with Women Empowered to be Exceptional (WE2), which is now a sustainable model for other Amgen field-based ERGs. Tamika received Bachelor of Science degree from Arkansas State University and Global Executive MBA from TRIUM (NYU, London School of Economics, HEC Paris). She also currently serves on the TRIUM DEI Council.

Vice-chair Nicola Greenway Sr. Vice President, Group Head of HR, Global Portfolio Division Takeda Pharmaceuticals, Inc.

Nicola Greenway

Sr. Vice President, Group Head of HR, Global Portfolio Division Takeda Pharmaceuticals, Inc.

Nicola Greenway is a purpose-driven leader who has held both commercial and HR leadership roles and who brings with her, extensive international experience, strong business acumen and entrepreneurial drive. She is a change agent, trusted advisor and thought partner to executive leaders, who has held Talent, DE&I, and Business Partner roles in FTSE 100, Fortune 500 and NYSE listed companies. Her core strength is helping organizations to develop and implement the people strategies required to achieve their short, medium and long-term business goals. Her commercial roles included strategy, business planning and management consulting. She has a respected mix of global/international experience including: management responsibilities for teams in US, Europe, Japan, China, Brazil and several other Emerging Markets countries; Multi-industry experience in Bio Pharmaceutical, Manufacturing, Financial Services and Professional Services sectors; Business impact in areas such as mergers, acquisitions and integrations, scaling for growth and revenue maximization, as well as rationalizations to drive operational efficiency and bottom line performance; Transformations through digital and data-driven innovations, Leadership Development, Culture and Values; and Diversity, Equity and Inclusion. As a member of Takeda’s Global Diversity Equity and Inclusion Council and the Executive Sponsor for Enables, Gender Parity Network, Women at Takeda Switzerland and the Black Leadership Council Switzerland, Nicola leverages her experience and networks to influence change. She is also a current member of the Board of the Healthcare Businesswomen’s Association (HBA). Through her engagement with each of these bodies, Nicola is passionate about influencing representation and inclusion across the health and life sciences industry.She holds a Masters degree in Employment Law from the University of Surrey, UK and an Executive MBA from ENPC, Paris and the University of Edinburgh, Scotland.

Secretary/Treasurer Marie-Caroline Chauvet Partner Insigniam

Marie-Caroline Chauvet

Partner Insigniam

CEO Mary Stutts CEO Healthcare Businesswomen's Association

Mary Stutts

CEO Healthcare Businesswomen's Association

Mary brings to the HBA 30 years of experience leading the strategic integration of corporate branding, marketing, health equity, inclusion and digital innovation for biopharma, healthcare, and media companies. Her expertise and cross functional acumen have provided global leadership to organizations and Fortune 500 companies including Genentech, Bayer, Bristol Myers Squibb, Sumitovant, UnitedHealth Group, Kaiser Permanente, Stanford Health Care and Comcast NBCUniversal. Previously Stutts was the Global Chief Inclusion and Health Equity Officer at Real Chemistry where she drove inclusion and equitable care for clients by integrating customized digital analytics and data intelligence to increase market penetration and clinical trial diversity. Among her many accomplishments, as the former Chief Inclusion and Health Equity Officer at Stanford Health Care, Stutts worked directly with the board to curate the Inclusive Leadership Workshop which was designed to develop executives capable of leading, growing and transforming organizations while addressing racial and social injustice and inequity amongst all stakeholders. Additionally, Stutts led Genentech’s $5 million Diversity in Clinical Trials initiative to increase the representation of people of color and women; enhanced a culture of workplace inclusion and health equity during Bristol Myers Squibb’s business model transformation; and oversaw fulfillment of the FCC’s digital equity conditions in Comcast’s California Region required for the acquisition of NBC Universal. Stutts is a recognized advocate of women in leadership and has been at the forefront of board readiness programs to increase the representation of women and people of color on public and private corporate boards. Stutts earned a Master of Health Administration degree at the University of Southern California and is a graduate of the Executive Program on Strategy and Organization at the Stanford University Graduate School of Business.

Directors at large

{1}

##LOC[OK]##

{1}

##LOC[OK]## ##LOC[Cancel]##

{1}

##LOC[OK]## ##LOC[Cancel]##

Dianne Auclair Rocha SVP and Therapeutic Area Head, Cardiovascular, Renal, Metabolic Novartis Corporation

Dianne Auclair Rocha

SVP and Therapeutic Area Head, Cardiovascular, Renal, Metabolic Novartis Corporation

Kathryn Becker Director Diagnostics Licensing & Acquisitions Abbott

Kathryn Becker

Director Diagnostics Licensing & Acquisitions Abbott

Tanya Botelho Silva Alcorn Senior Vice President, Sterile Injectables / Biotech Operations Pfizer Inc.

Tanya Botelho Silva Alcorn

Senior Vice President, Sterile Injectables / Biotech Operations Pfizer Inc.

Deepa Desai Founder and CEO - D Cube Consultancy

Deepa Desai

Founder and CEO - D Cube Consultancy

Adam Dubow General Counsel Day One Biopharmaceuticals, Inc.

Adam Dubow

General Counsel Day One Biopharmaceuticals, Inc.

A senior executive with global experience, Adam has been a strategic C-Suite leader, including on issues of corporate governance, risk, ethics, and compliance.
Adam currently is General Counsel for Day One Biopharmaceuticals, a clinical stage biopharmaceutical company dedicated to developing and commercializing innovative targeted therapies for patients of all ages. Over the course of a distinguished 22-year career with Bristol Myers Squibb – a Fortune 100 company with global operations and more than 30,000 employees – Adam developed expert knowledge of the pharmaceutical industry and the complex regulatory environment that governs it. In addition to legal and compliance expertise, Adam brings an innovative and solution-oriented approach to his work, along with a passion for patient welfare, focus on the business, and the highest ethical standards and personal integrity. As Chief Compliance and Ethics Officer at Bristol Myers Squibb, Adam served on the Management Team, contributing to the creation and implementation of the Company’s strategy. As Chief Compliance and Ethics Officer, he implemented a series of initiatives – including a company-wide integrity commitment campaign – that strengthened the company’s culture of compliance and ethics while at the same time successfully integrating the Compliance and Ethics Team into the company’s Law Department. By the time Adam completed his three-year term as its leader, the Compliance and Ethics Department was independently assessed by Ethisphere as a best-in-class global compliance program. Throughout his career, Adam has been a champion of diversity, equity, and inclusion. He has served as co-chair of the “Engaging Men” workstream within the Bristol Myers Squibb Network of Women, was Executive Sponsor of the BMS Law Department’s Diversity and Inclusion Committee, and is also a member of the Global Board of the Healthcare Businesswomen’s Association.